Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 486 | 2021 |
Treatment of Multisystem Inflammatory Syndrome in Children BC A.J. McArdle, O. Vito, H. Patel, E.G. Seaby, P. Shah, C. Wilson, C ... N Engl J Med, 2021 | 363* | 2021 |
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 361 | 2021 |
SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease? JLCSYZ Vanessa Sancho-Shimizu, Petter Brodin, Aur´elie Cobat, Catherine M ... J. Exp. Medicine 218 (6), 1-16, 2021 | 148 | 2021 |
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 145 | 2022 |
The epidemiology of adolescents living with perinatally acquired HIV: a cross-region global cohort analysis Collaborative Initiative for Paediatric HIV Education and Research (CIPHER ... PLoS medicine 15 (3), e1002514, 2018 | 122 | 2018 |
X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world ZA El-Sayed, I Abramova, JC Aldave, W Al-Herz, L Bezrodnik, R Boukari, ... World Allergy Organization Journal 12 (3), 100018, 2019 | 118 | 2019 |
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children G Lee, D., Le Pen, J., Yatim, A., ...Zawadzki, P., Zuccotti Science 379 (6632), 2023 | 91* | 2023 |
Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study B Tóth, A Volokha, A Mihas, M Pac, E Bernatowska, I Kondratenko, ... Molecular immunology 46 (10), 2140-2146, 2009 | 71 | 2009 |
The European Society for Immunodeficiencies (ESID) registry 2014 ERWP B. Grimbacher Clin Exp Immunology 78 (Suppl 1), 18-20, 2014 | 65 | 2014 |
Інфекційні хвороби у дітей СО Крамарьов, ОБ Надрага, ОР Буц, ОВ Виговська, АП Волоха, ... Медицина, 2023 | 54 | 2023 |
Физиологические и терапевтические свойства лактобактерий ОП Костюк, ЛИ Чернышова, АП Волоха Педиатрия 1, 71-76, 1998 | 52 | 1998 |
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs P Bastard, SE Vazquez, J Liu, MT Laurie, CY Wang, A Gervais, ... Science immunology 8 (90), eabp8966, 2023 | 47 | 2023 |
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 A Matuozzo, D., Talouarn, E., Marchal, A., ...Abel, L., Cobat Genome Medicine 15 (1), 22, 2023 | 46 | 2023 |
Antibiotic policies in Central Eastern Europe AV M Cizman, B Beovic, V Krcmery, B Barsic, E Tamm, E Ludwig, M Pelemis, K ... International Journal of Antimicrobial Agents, 1-6, 2004 | 46* | 2004 |
The impact of combining educational program with the improving of infrastructure to diagnose on early detection of primary immunodeficiencies in children O Boyarchuk, A Volokha, T Hariyan, M Kinash, L Volyanska, I Birchenko, ... Immunologic Research 67 (4), 390-397, 2019 | 42 | 2019 |
Епштейн—Барр вірусна інфекція у дітей АП Волоха Современная педиатрия, 103-110, 2015 | 41 | 2015 |
Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle-and high-income … European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study ... PLoS medicine 15 (1), e1002491, 2018 | 39 | 2018 |
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial The Lancet HIV 3 (9), e421-e430, 2016 | 36 | 2016 |
Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration IJ Collins, K Wools-Kaloustian, R Goodall, C Smith, EJ Abrams, ... The Lancet HIV 6 (2), e105-e115, 2019 | 27 | 2019 |